A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia

Viatris

Status and phase: Completed; Phase 3

Conditions: Neuralgia, Postherpetic

Treatments: Drug: pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00424372

A0081121

Details and patient eligibility

About

To evaluate the safety of the long-term use of pregabalin.

Enrollment: 126 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who completed the 13-week treatment of postherpetic neuralgia in Study A0081120.
• Patients must be able to understand and cooperate with study procedures and have signed a written informed consent prior to entering the study.

Exclusion criteria

• Patients who experienced serious adverse events in the preceding study (A0081120) that were determined by the investigator or the study sponsor to be causally related to the study medication.
• Patients exhibiting treatment non-compliance in the preceding study (A0081120)

Trial design

126 participants in 1 patient group

pregabalin

Experimental group

Treatment:

Drug: pregabalin